San Antonio, TX, United States of America

Yasuteru Sakurai

This inventor holds 1 USPTO granted patent. Top assignee: Kagoshima University. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuteru Sakurai. Retrieved from https://idiyas.com/inventor/yasuteru-sakurai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuteru Sakurai: Innovator in Pharmaceutical Compositions

Introduction

Yasuteru Sakurai is a notable inventor based in San Antonio, TX (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target viral infections. His work is characterized by a focus on innovative methods to block viral entry into host cells.

Latest Patents

Sakurai holds a patent for "Amodiaquine analogs and methods of uses thereof." This patent describes pharmaceutical compositions capable of blocking the entry of a virus into a host cell. The compositions contain one or more compounds of a specific general formula or a pharmaceutically acceptable derivative. The methods outlined in the patent are aimed at treating viral infections through treatment or prophylactic administration.

Career Highlights

Sakurai is affiliated with Kagoshima University, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on public health, particularly in the context of viral diseases.

Collaborations

Throughout his career, Sakurai has collaborated with esteemed colleagues, including Robert A. Davey and Masanori Baba. These collaborations have contributed to the depth and breadth of his research efforts.

Conclusion

Yasuteru Sakurai's innovative work in pharmaceutical compositions highlights his commitment to addressing viral infections through scientific research. His contributions are paving the way for new treatment options in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…